Fidelity Investments’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.57M | Buy |
278,736
+73,312
| +36% | +$1.87M | ﹤0.01% | 2208 |
|
|
2025
Q4 | $5.97M | Buy |
205,424
+37,450
| +22% | +$959K | ﹤0.01% | 2223 |
|
|
2025
Q3 | $3.17M | Buy |
167,974
+17,244
| +11% | +$272K | ﹤0.01% | 2388 |
|
|
2025
Q2 | $2.11M | Sell |
150,730
-11,719
| -7% | -$164K | ﹤0.01% | 2471 |
|
|
2025
Q1 | $2.54M | Sell |
162,449
-22,110
| -12% | -$311K | ﹤0.01% | 2370 |
|
|
2024
Q4 | $2.57M | Buy |
184,559
+13,340
| +8% | +$146K | ﹤0.01% | 2361 |
|
|
2024
Q3 | $1.59M | Buy |
171,219
+34,884
| +26% | +$344K | ﹤0.01% | 2463 |
|
|
2024
Q2 | $1.27M | Sell |
136,335
-4,763
| -3% | -$43.1K | ﹤0.01% | 2460 |
|
|
2024
Q1 | $1.4M | Sell |
141,098
-1,081,306
| -88% | -$8.07M | ﹤0.01% | 2422 |
|
|
2023
Q4 | $3.95M | Sell |
1,222,404
-7,039,638
| -85% | -$19.1M | ﹤0.01% | 2123 |
|
|
2023
Q3 | $43.9M | Sell |
8,262,042
-950,744
| -10% | -$8.09M | ﹤0.01% | 1295 |
|
|
2023
Q2 | $87.8M | Buy |
9,212,786
+50,356
| +0.5% | +$559K | 0.01% | 1055 |
|
|
2023
Q1 | $101M | Buy |
9,162,430
+23,257
| +0.3% | +$336K | 0.01% | 985 |
|
|
2022
Q4 | $135M | Buy |
9,139,173
+209,942
| +2% | +$3.67M | 0.01% | 848 |
|
|
2022
Q3 | $171M | Buy |
8,929,231
+1,216,551
| +16% | +$27.6M | 0.02% | 734 |
|
|
2022
Q2 | $164M | Buy |
7,712,680
+155,087
| +2% | +$3.18M | 0.02% | 771 |
|
|
2022
Q1 | $146M | Buy |
7,557,593
+13,381
| +0.2% | +$226K | 0.01% | 910 |
|
|
2021
Q4 | $156M | Buy |
7,544,212
+7,947
| +0.1% | +$158K | 0.01% | 894 |
|
|
2021
Q3 | $180M | Buy |
7,536,265
+5,525
| +0.1% | +$126K | 0.01% | 852 |
|
|
2021
Q2 | $206M | Sell |
7,530,740
-105,709
| -1% | -$2.98M | 0.02% | 819 |
|
|
2021
Q1 | $221M | Buy |
7,636,449
+1,091,285
| +17% | +$34.1M | 0.02% | 747 |
|
|
2020
Q4 | $184M | Buy |
6,545,164
+816,771
| +14% | +$20M | 0.02% | 780 |
|
|
2020
Q3 | $168M | Buy |
5,728,393
+5,211
| +0.1% | +$139K | 0.02% | 699 |
|
|
2020
Q2 | $173M | Buy |
5,723,182
+9,839
| +0.2% | +$284K | 0.02% | 662 |
|
|
2020
Q1 | $170M | Buy |
+5,713,343
| New | +$154M | 0.02% | 558 |
|
Other funds holding ARQT
SCM
FLSM
RCMNY
PCH
VCM
GGHC
